UNSPSC 51263504: Hexoprenaline sulfate

This classification denotes a beta-adrenergic agonist with the molecular formula C22H32N2O6.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U851S9102C, chemically known as 4,4-(hexane-1,6-diylbis(iminio(1-hydroxyethylene)))dipyrocatecholsulphate but more generally known as hexoprenaline sulfate, which bears US NIH Compound Identifier 36094. European Medicines Agency schedules Hexoprenaline sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02516MIG.

UNSPSC 51263504 Hexoprenaline sulfate is a Commodity code that in practice captures state and local procurement of emergency-response pharmaceuticals and related medical supplies. Recent state and local opportunities tagged under this code show solicitation of naloxone (opioid-reversal medication) and drug deactivation systems for community health programs, as well as market-research activity around direct-to-manufacturer pharmacy programs. The actual buying under this code reflects county health departments and state health agencies sourcing controlled pharmaceuticals, emergency medical countermeasures, and pharmacy-program infrastructure to support opioid-crisis response and public-health initiatives. Issuing bodies include county health departments and state health and human services agencies.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, gathering vendor information on direct-to-manufacturer prescription programs to improve pharmacy benefit delivery and cost management across the state's health plans. Both solicitations indicate active state and local investment in pharmaceutical procurement and supply-chain modernization, particularly in the South and Southwest, though the code's overall activity remains limited to these two recent entries. Vendors responding to Seminole County's IFB must provide unit pricing, satisfy E-Verify and drug-free workplace requirements, and carry workers' compensation and commercial general liability insurance; the county's RFI in Texas signals exploratory procurement intent around pharmacy restructuring before formal RFP issuance.